Security key
05350V106
AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS)
CUSIP: 05350V106
Q2 2021 13F Holders as of 30 Jun 2021
- Security type / class
- Equity / Common Stock - $0.01 Par Value
- Total 13F shares
- 44,393,122
- Total 13F value
- $1,614,401,834
- Share change
- +279,930
- SEC-reported price per share
- $36.37
- Number of holders
- 239
- Value change
- +$1,417,948
- Number of buys
- 100
- Number of sells
- 100
- Shares outstanding
- 46,511,628
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2021
Institutions
239
Top holders
10
AVNS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2021
Previous quarter: Q1 2021
AVANOS MEDICAL, INC. SEC filings
AVANOS MEDICAL, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 05350V106
Recent filing periods:
Ownership snapshot
Top reported holders of AVNS - AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
15/15
Latest evidence
31 Mar 2021
13F
Lead comparable stake: 12%
Showing 1-6 of 15 holder rows.
Quick read
BlackRock Finance, Inc. leads the comparable SEC ownership view at 12%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock Finance, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock Finance, Inc.
12%
VANGUARD GROUP INC
9.6%
WELLINGTON MANAGEMENT GROUP LLP
8.5%
PRICE T ROWE ASSOCIATES INC /MD/
6.9%
Champlain Investment Partners, LLC
6.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
Company
|
12%
|
$245,428,000
5,611,068 shares
|
— | 31 Mar 2021 |
| VANGUARD GROUP INC |
13F
Company
|
9.6%
|
$196,141,000
4,484,264 shares
|
— | 31 Mar 2021 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
8.5%
|
$172,282,000
3,938,796 shares
|
— | 31 Mar 2021 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
6.9%
|
$140,881,000
3,220,883 shares
|
— | 31 Mar 2021 |
| Champlain Investment Partners, LLC |
13F
Company
|
6.3%
|
$127,379,000
2,912,188 shares
|
— | 31 Mar 2021 |
| Paradice Investment Management LLC |
13F
Company
|
5.3%
|
$107,876,000
2,466,294 shares
|
— | 31 Mar 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
239
Shares
44,393,122
Rows available
239
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
251
Q2 2021 holders
239
Holder diff
-12
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 value | Q2 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend